157 related articles for article (PubMed ID: 2127786)
1. A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.
Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Goodman Z; Banks SM; Hoofnagle JH
J Hepatol; 1990; 11 Suppl 1():S36-42. PubMed ID: 2127786
[TBL] [Abstract][Full Text] [Related]
2. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.
Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Murray L; Waggoner J; Goodman Z; Banks SM; Hoofnagle JH
N Engl J Med; 1989 Nov; 321(22):1506-10. PubMed ID: 2509917
[TBL] [Abstract][Full Text] [Related]
3. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trial.
Realdi G; Diodati G; Bonetti P; Scaccabarozzi S; Alberti A; Ruol A
J Hepatol; 1990; 11 Suppl 1():S68-71. PubMed ID: 2127791
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis.
Saracco G; Rosina F; Torrani Cerenzia MR; Lattore V; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Donegani E; Solinas A
J Hepatol; 1990; 11 Suppl 1():S43-9. PubMed ID: 2127787
[TBL] [Abstract][Full Text] [Related]
6. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis.
Bresci G; Del Corso L; Romanelli AM; Giuliano G; Pentimone F
J Am Geriatr Soc; 1993 Aug; 41(8):857-62. PubMed ID: 7688007
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
[TBL] [Abstract][Full Text] [Related]
8. Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience.
Weiland O; Schvarcz R; Wejstål R; Norkrans G; Frydén A
J Hepatol; 1990; 11 Suppl 1():S57-62. PubMed ID: 2127789
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
Wright TL; Combs C; Kim M; Ferrell L; Bacchetti P; Ascher N; Roberts J; Wilber J; Sheridan P; Urdea M
Hepatology; 1994 Oct; 20(4 Pt 1):773-9. PubMed ID: 7927216
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon alfa-2b treatment in chronic non-A, non-B/type C hepatitis.
De Conca V; Mesiti S; Vallarino E; Mornese A; Dodero M
Gut; 1993; 34(2 Suppl):S126. PubMed ID: 8314477
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.
Omata M; Ito Y; Yokosuka O; Imazeki F; Tagawa M; Takano S; Hosoda K; Tada M; Ohto M; Ito K
Dig Dis Sci; 1991 Sep; 36(9):1217-22. PubMed ID: 1654240
[TBL] [Abstract][Full Text] [Related]
12. A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels. Nephrologists' Group for the Study of HCV infection.
Fernández JL; Rendo P; del Pino N; Viola L
J Viral Hepat; 1997 Mar; 4(2):113-9. PubMed ID: 9097267
[TBL] [Abstract][Full Text] [Related]
13. One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2b.
Ferenci P; Vogel W; Pristautz H; Deimer J; Denk H; Judmaier G; Maier KP; Krejs GJ; Gangl A
J Hepatol; 1990; 11 Suppl 1():S50-3. PubMed ID: 2127788
[TBL] [Abstract][Full Text] [Related]
14. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
[TBL] [Abstract][Full Text] [Related]
15. Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C.
Pérez R; Pravia R; Linares A; Rodríguez M; Lombraña JL; Suárez A; Riestra S; Navascués CA; Rodrigo L
Gut; 1993; 34(2 Suppl):S139-40. PubMed ID: 8314482
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group.
Lin R; Roach E; Zimmerman M; Strasser S; Farrell GC
J Hepatol; 1995 Nov; 23(5):487-96. PubMed ID: 8583134
[TBL] [Abstract][Full Text] [Related]
18. Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion.
Colombo M; Lampertico P; Rumi M
Gut; 1993; 34(2 Suppl):S141. PubMed ID: 8314483
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
20. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
